ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 148 filers reported holding ACORDA THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,119,192,000 | -31.2% | 136,020 | -13.3% | 0.17% | -14.1% |
| Q3 2018 | $3,081,769,000 | -33.2% | 156,833 | -2.5% | 0.20% | -40.4% |
| Q2 2018 | $4,615,247,000 | +82.4% | 160,810 | +50.3% | 0.33% | +75.8% |
| Q1 2018 | $2,530,550,000 | +30.0% | 107,000 | +17.9% | 0.19% | +25.0% |
| Q4 2017 | $1,946,952,000 | +1342625.5% | 90,767 | +1965.2% | 0.15% | +4.1% |
| Q2 2013 | $145,000 | – | 4,395 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |